New scan aims to sharpen detection of Hard-to-Find tumors
NCT ID NCT06240741
Summary
This study tested a new type of PET/CT scan to see if it could better detect neuroendocrine tumors compared to standard imaging. It involved 71 people in Japan, including patients with confirmed or suspected tumors and healthy volunteers. The main goal was to see how accurate the new scan was at correctly identifying who had tumors and who did not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Kashiwa, Chiba, 277 8577, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 060 8648, Japan
-
Novartis Investigative Site
Kanazawa, Ishikawa-ken, 920 8641, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa-ku, 236-0004, Japan
-
Novartis Investigative Site
Chuo Ku, Tokyo, 1040045, Japan
-
Novartis Investigative Site
Fukuoka, 8128582, Japan
-
Novartis Investigative Site
Fukuoka, 813-0017, Japan
-
Novartis Investigative Site
Kyoto, 6068507, Japan
Conditions
Explore the condition pages connected to this study.